Stroke Clinical Trial
Official title:
Secondary Stroke Prevention In Patients With Patent Foramen Ovale: International PFO Consortium
The prevalence of patent foramen ovale (PFO) is about 25% in the general population and approximately 40% in patients who have ischemic stroke of unknown cause (cryptogenic stroke). Given the large number of asymptomatic patients, no primary prevention is currently recommended. On the contrary, secondary prevention is very important. Prospective studies have shown that antithrombotic treatment (ATT) with aspirin or warfarin appears to negate the risk of recurrent stroke associated with a PFO. Patients with spontaneous or large right-to-left shunts (RLS), those with a coinciding atrial septal aneurysm (ASA) or multiple ischemic events prior to the PFO diagnosis may still be at increased risk of stroke recurrence despite ATT. Percutaneous device closure (PDC) is a challenging alternative to ATT. Several studies reported 0% to 3.4% annual recurrence rates of stroke or TIA in patients treated by PDC. To date, there is no data from randomized controlled trials (RCT) comparing the risk of stroke recurrence after PDC with that under ATT only. The results from ongoing RCTs are not to be awaited in the near future, mainly due to low enrolment and event rates. Alternative data-gathering strategies such as multicenter registries are needed to overcome the low recruitment rates. The aim of the present study is to compare the risk of recurrent stroke and TIA in patients with PFO and otherwise unexplained stroke who undergo PDC or receive ATT.
Background
The prevalence of patent foramen ovale (PFO) is about 25% in the general population and
approximately 40% in patients who have ischemic stroke of unknown cause (cryptogenic stroke).
Given the large number of asymptomatic patients, no primary prevention is currently
recommended. On the contrary, secondary prevention is very important. Prospective studies
have shown that antithrombotic treatment (ATT) with aspirin or warfarin appears to negate the
risk of recurrent stroke associated with a PFO. Patients with spontaneous or large
right-to-left shunts (RLS), those with a coinciding atrial septal aneurysm (ASA) or multiple
ischemic events prior to the PFO diagnosis may still be at increased risk of stroke
recurrence despite ATT. Percutaneous device closure (PDC) is a challenging alternative to
ATT. Several studies reported 0% to 3.4% annual recurrence rates of stroke or TIA in patients
treated by PDC. To date, there is no data from randomized controlled trials (RCT) comparing
the risk of stroke recurrence after PDC with that under ATT only. The results from ongoing
RCTs are not to be awaited in the near future, mainly due to low enrolment and event rates.
Even if RCTs are completed successfully, statistical differences may remain undetected with
the planned sample sizes. Alternative data-gathering strategies such as multicenter
registries are needed to overcome the low recruitment rates.
Objective
1) To compare the risk of recurrent stroke and TIA in patients aged ≤ 55 years with PFO and
otherwise unexplained stroke who undergo PDC or receive ATT only; 2) To assess the
etiological role of PFO for stroke/TIA in patients aged > 55 years; 3) To assess the risk of
recurrent stroke/TIA in "high-risk" PFO patients (i.e. those with spontaneous (at rest) or
large RLS, coinciding ASA, or multiple previous cerebrovascular events).
Methods
Multicenter prospective non-randomized study with scheduled 3-years follow-up of patients
with PFO and ischemic stroke or TIA. Participating centers: Swiss University Hospitals of
Basel, Bern, Geneva, Lausanne and Zurich, the Cantonal Hospital of Aarau, the Triemli
Hospital, the Alfried-Krupp Krankenhaus of Essen, the University Hospital of Essen, the
Klinikum Worms gGmbH, Tufts Medical Center, Baystate Medical Center, the East Medical Center
Tyler, and the University Hospital of Leuven.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Recruiting |
NCT03869138 -
Alternative Therapies for Improving Physical Function in Individuals With Stroke
|
N/A | |
Completed |
NCT04034069 -
Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial
|
N/A | |
Completed |
NCT04101695 -
Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects
|
N/A | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Completed |
NCT00391378 -
Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS)
|
N/A | |
Recruiting |
NCT06204744 -
Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial
|
N/A | |
Active, not recruiting |
NCT06043167 -
Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
|
||
Active, not recruiting |
NCT04535479 -
Dry Needling for Spasticity in Stroke
|
N/A | |
Completed |
NCT03985761 -
Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke
|
N/A | |
Recruiting |
NCT06034119 -
Effects of Voluntary Adjustments During Walking in Participants Post-stroke
|
N/A | |
Completed |
NCT03622411 -
Tablet-based Aphasia Therapy in the Chronic Phase
|
N/A | |
Completed |
NCT01662960 -
Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke
|
N/A | |
Recruiting |
NCT05854485 -
Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke
|
N/A | |
Active, not recruiting |
NCT05520528 -
Impact of Group Participation on Adults With Aphasia
|
N/A | |
Completed |
NCT03366129 -
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
|
||
Completed |
NCT05805748 -
Serious Game Therapy in Neglect Patients
|
N/A | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT05621980 -
Finger Movement Training After Stroke
|
N/A | |
Recruiting |
NCT05993221 -
Deconstructing Post Stroke Hemiparesis
|